|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DK |
First Approval Date01 Jan 1989 |
Phase II Study Using Nexalin Therapy for the Treatment of Depressive Symptoms Associated With Mild to Moderate Depression Episodes
The primary objectives of this Phase II study are to demonstrate the safety of Nexalin Therapy and to investigate the efficacy of Nexalin Therapy.
100 Clinical Results associated with Kalaco Scientific, Inc.
0 Patents (Medical) associated with Kalaco Scientific, Inc.
100 Deals associated with Kalaco Scientific, Inc.
100 Translational Medicine associated with Kalaco Scientific, Inc.